BeiGene (NASDAQ:BGNE) Earns Outperform Rating from Analysts at Royal Bank of Canada
Stock analysts at Royal Bank of Canada started coverage on shares of BeiGene (NASDAQ:BGNE – Get Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The firm set an “outperform” rating and a $259.00 price target on the stock. Royal Bank of Canada’s price target would suggest a potential upside of […]